PROLACTA BIOSCIENCE INC
Duarte, CA · CIK 0001294955 · Biotech · Acquired
Human milk-based nutritional products and formulations for preterm and critically ill infants
prolacta.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $65M
- 4 Form D · May 2018
- 101 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 10 granted · 30 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112012201320142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,783,892 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $34,999,997 | |
| Private capital raised | Form D · SEC | $8,908,625 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1130 | OMVAX, INC. | — | — |
| 1131 | Denali Therapeutics | — | $500M |
| 1132 | MS Biotech Holdings, Inc. | — | $59M |
| 1133 | PROLACTA BIOSCIENCE INC | — | $65M |
| 1134 | CalciMedica Subsidiary, Inc. | — | $67M |
| 1135 | Vergent Bioscience, Inc. | — | $54M |
| 1136 | REGENOSINE INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John BacichDirector
- John Bacich Jr.Director
- John Bacich, Jr.Director
- David BrailerDirector
- Ned BrownDirector
- Tami CirannaExecutive Officer
- Sally CrawfordDirector
- David CreminDirector
- David DreyerExecutive Officer
- Scott EakerExecutive Officer
- Scott ElsterDirector · Executive Officer
- Frank FosterDirector
- Joseph FournellExecutive Officer
- Alyson FullerExecutive Officer
- Vincent GasparExecutive Officer
- Mark HannonExecutive Officer
- Dan JanneyDirector
- Alison KileyDirector
- Alan KofskyExecutive Officer
- Martin LeeExecutive Officer
- Victoria NiklasExecutive Officer
- Joshua SaipeDirector
- John ShieldsExecutive Officer
- John M. ShieldsExecutive Officer
- Ernie StrapazonDirector
- Martin SutterDirector
- Stephen WatkinsDirector
Patents
- Synbiotic Treatment Regimensapplication
- Compositions And Methods For Treatment Of Inflammatory And Immune Diseasesgranted
- Methods For Obtaining Sterile Milk And Compositions Thereofapplication
- Systems, Devices, And Methods For Management Of Milk Allocationapplication
- Purified Human Milk Oligosaccharides Compositionsapplication
- Human Milk Permeate Compositions And Methods Of Making And Using Sameapplication
- High Fat Human Milk Productsapplication
- Human Milk Products Useful In Pre- And Post-operative Careapplication
- High Fat Human Milk Productsgranted
- Human Milk Products Useful In Pre- And Post-operative Caregranted
- Methods Of Treatment For Failure To Thriveapplication
- Human Milk Oligosaccharide Compositions For Use With Bacteriotherapiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.